Private investors have acquired ORO PAY, a Cyprus-registered EMI
A group of private investors have acquired ORO PAY, a fast-growing electronic money institution (EMI) licensed by the Central Bank of Cyprus.
ORO PAY offers secure and convenient payment solutions licensed by the Central Bank of Cyprus. Catering to the needs of both individuals and corporate clients, ORO PAY provides a seamless and cost-effective alternative for merchants and users. Its intuitive payment account solution is designed to enhance the convenience of financial transactions for businesses and individuals.
Oaklins’ teams in Latvia and Cyprus advised the buyer, identified the target and executed the transaction. The team in Cyprus also performed the regulatory due diligence and supported the buyer in the application and communication with the Central Bank of Cyprus.
Panayiotis Konstantinou
CEO, ORO PAY
Talk to the deal team
Related deals
Niscon Inc. has been acquired by SGPS ShowRig
Niscon Inc. has been successfully acquired by SGPS ShowRig, a global provider of staging, rigging and automation for live entertainment. The acquisition reinforces SGPS Showrig’s commitment to pushing the boundaries of innovation in the entertainment industry. By adding Niscon’s unique motion-control technology to its portfolio, SGPS Showrig strengthens its ability to deliver cutting-edge, precision-driven solutions.
Learn moreFairfest Media has acquired WTE Miami
Fairfest Media, organizer of OTM, the leading travel show in Asia, has acquired WTE Miami, the fastest-growing travel trade show in the USA. The acquisition marks a significant milestone in Fairfest’s global expansion, strengthening its presence in the Americas and beyond by leveraging decades of experience and leadership in Asia and India.
Learn moreBanook, backed by Motion Equity, has acquired Fluidda
Banook Group has acquired Fluidda NV, marking a strategic expansion into advanced in-silico trials and respiratory disease modeling. Combining Banook’s expertise in cardiac safety and clinical data services with Fluidda’s AI-driven respiratory analytics creates a powerful, integrated platform. This deal strengthens Banook’s position in the contract research organization (CRO) sector, offering pharmaceutical clients broader, technology-enabled solutions to drive drug development and reduce costs.
Learn more